Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HengLi Botulinum Toxin Type A for Overactive Bladder
NCT02786407Phase 3Unknown
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Mar 2016
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of lanbotulinumtoxin-A in overactive bladder (OAB), sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Status: unknown.
02
Drugs
lanbotulinumtoxin-A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02786407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786407.